58 related articles for article (PubMed ID: 19526591)
1. Hormone Replacement Therapy and Psoriasis Risk: A Nationwide Population-Based Cohort Study.
Go GM; Oh HJ; Han K; Kim YH; Lee HJ; Lee JH
J Korean Med Sci; 2023 Dec; 38(49):e377. PubMed ID: 38111280
[TBL] [Abstract][Full Text] [Related]
2. Hormone Replacement Therapy and Risks of Various Cancers in Postmenopausal Women with De Novo or a History of Endometriosis.
Lee HJ; Lee B; Choi H; Lee M; Lee K; Lee TK; Hwang SO; Kim YB
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398200
[TBL] [Abstract][Full Text] [Related]
3. Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review.
Fiol G; Lete I; Nieto L; Santaballa A; Pla MJ; Baquedano L; Calaf J; Coronado P; de la Viuda E; Llaneza P; Otero B; Sánchez-Méndez S; Ramírez I; Mendoza N;
J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629305
[No Abstract] [Full Text] [Related]
4. Expression and clinical implications of estrogen receptors in thoracic malignancies: a narrative review.
Pinton G; Manzotti B; Balzano C; Moro L
J Thorac Dis; 2021 Mar; 13(3):1851-1863. PubMed ID: 33841973
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy in women with cancer and risk of cancer-specific mortality and cardiovascular disease: a protocol for a cohort study from Scotland and Wales.
McMenamin Ú; Hicks B; Hughes C; Murchie P; Hippisley-Cox J; Ranger T; Coupland C; Cardwell C
BMC Cancer; 2021 Mar; 21(1):313. PubMed ID: 33761919
[TBL] [Abstract][Full Text] [Related]
6. Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancer.
Deng S; Ramos-Castaneda M; Velasco WV; Clowers MJ; Gutierrez BA; Noble O; Dong Y; Zarghooni M; Alvarado L; Caetano MS; Yang S; Ostrin EJ; Behrens C; Wistuba II; Stabile LP; Kadara H; Watowich SS; Moghaddam SJ
Carcinogenesis; 2020 Nov; 41(11):1529-1542. PubMed ID: 32603404
[TBL] [Abstract][Full Text] [Related]
7. The prognostic factors of recurrence and survival in female patients with lung adenocarcinoma and breast cancer.
Chen YY; Huang YJ; Huang HK; Chang H; Lee SC; Shieh YS; Huang TW
J Cancer Res Clin Oncol; 2020 May; 146(5):1299-1306. PubMed ID: 32107626
[TBL] [Abstract][Full Text] [Related]
8. Expression of estrogen receptor beta and overall survival in non-small cell lung cancer patients: Protocol for a systematic review and meta-analysis of cohort studies.
Chen H; Yan M; Shi W; Shi J; Duan C; Fan Q; Wang Y; Li H
Medicine (Baltimore); 2019 Oct; 98(43):e17559. PubMed ID: 31651857
[TBL] [Abstract][Full Text] [Related]
9. Estrogen, Estrogen Receptor and Lung Cancer.
Hsu LH; Chu NM; Kao SH
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28783064
[TBL] [Abstract][Full Text] [Related]
10. Exploring estrogenic activity in lung cancer.
Słowikowski BK; Lianeri M; Jagodziński PP
Mol Biol Rep; 2017 Feb; 44(1):35-50. PubMed ID: 27783191
[TBL] [Abstract][Full Text] [Related]
11. Estrogen Plus Progestin and Lung Cancer: Follow-up of the Women's Health Initiative Randomized Trial.
Chlebowski RT; Wakelee H; Pettinger M; Rohan T; Liu J; Simon M; Tindle H; Messina C; Johnson K; Schwartz A; Gass M; Wactawski-Wende J
Clin Lung Cancer; 2016 Jan; 17(1):10-7.e1. PubMed ID: 26577506
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of Per1, Per2 and Per3 and their prognostic relevance in non-small cell lung cancer.
Liu B; Xu K; Jiang Y; Li X
Int J Clin Exp Pathol; 2014; 7(11):7863-71. PubMed ID: 25550826
[TBL] [Abstract][Full Text] [Related]
13. Estrogen adversely affects the prognosis of patients with lung adenocarcinoma.
Hsu LH; Liu KJ; Tsai MF; Wu CR; Feng AC; Chu NM; Kao SH
Cancer Sci; 2015 Jan; 106(1):51-9. PubMed ID: 25338663
[TBL] [Abstract][Full Text] [Related]
14. Menopausal hormone therapy and lung cancer-specific mortality following diagnosis: the California Teachers Study.
Clague J; Reynolds P; Henderson KD; Sullivan-Halley J; Ma H; Lacey JV; Chang S; Delclos GL; Du XL; Forman MR; Bernstein L
PLoS One; 2014; 9(7):e103735. PubMed ID: 25079077
[TBL] [Abstract][Full Text] [Related]
15. Survival in women with NSCLC: the role of reproductive history and hormone use.
Katcoff H; Wenzlaff AS; Schwartz AG
J Thorac Oncol; 2014 Mar; 9(3):355-61. PubMed ID: 24496005
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.
Chlebowski RT; Anderson GL; Manson JE; Schwartz AG; Wakelee H; Gass M; Rodabough RJ; Johnson KC; Wactawski-Wende J; Kotchen JM; Ockene JK; O'Sullivan MJ; Hubbell FA; Chien JW; Chen C; Stefanick ML
J Natl Cancer Inst; 2010 Sep; 102(18):1413-21. PubMed ID: 20709992
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer in women: role of estrogens.
Chakraborty S; Ganti AK; Marr A; Batra SK
Expert Rev Respir Med; 2010 Aug; 4(4):509-18. PubMed ID: 20658912
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial.
Chlebowski RT; Schwartz AG; Wakelee H; Anderson GL; Stefanick ML; Manson JE; Rodabough RJ; Chien JW; Wactawski-Wende J; Gass M; Kotchen JM; Johnson KC; O'Sullivan MJ; Ockene JK; Chen C; Hubbell FA;
Lancet; 2009 Oct; 374(9697):1243-51. PubMed ID: 19767090
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and survival in lung cancer in postmenopausal women in a rural population.
Huang B; Carloss H; Wyatt SW; Riley E
Cancer; 2009 Sep; 115(18):4167-75. PubMed ID: 19526591
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
